Picture of POINT Biopharma Global logo

PNT — POINT Biopharma Global News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Brief: Point Biopharma Publishes Preclinical Data For Actinium-Labelled Pnt2001

Oct 17 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA PUBLISHES PRECLINICAL DATA FOR
ACTINIUM-LABELLED
PNT2001, A NEXT-GENERATION PSMA LIGAND, AT EANM’S ANNUAL
CONGRESS
    * POINT BIOPHARMA GLOBAL INC - TARGETING IND/CTA SUBMISSION
FOR
PNT2001 PROGRAM IN H1 2023

Source text for Eikon:  ID:nGNX5ctFJZ 
Further company coverage:  PNT.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on POINT Biopharma Global

See all news